-+ 0.00%
-+ 0.00%
-+ 0.00%

Johnson & Johnson: Tom Kavanagh will succeed Jennifer Taubert as Executive Vice President and Global Chairman of the Innovative Drugs Division.

智通財經·08/04/2026 12:49:09
語音播報
Johnson & Johnson: Tom Kavanagh will succeed Jennifer Taubert as Executive Vice President and Global Chairman of the Innovative Drugs Division.